Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with (99m)Tc scintigraphy

Hepato-Gastroenterology

Volumn 47, Issue 32, 2000, Pages 405-413

  Sirisriro, Rojana ^a   Boonkitticharoen, Vipa ^b   Kraiphibul, Puangthong ^b   Ratanatharathorn, Vorachai ^b   Sumboonnanon, Kanit ^b   Kanjanapitak, Auchi ^b   Kuhapremma, Tirawoot ^b   Sritara, Chanika ^b   Puchinda, Duangpen ^b   Chouplywech, Putthiporn ^b   Jalayondeja, Virawat ^b   Pekanan, Petcharin ^b   Rochanawutanon, Mana ^b   Intaramarn, Chindarat ^b   Ayudhya, Anna Ngonrath Na ^b   Chokesuwathana, Payap ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NONE

Author keywords

Carcinoma; CEA; Colorectal; Immunoscintigraphy; Monoclonal antibody

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY IOR CEA1; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOSCINTIGRAPHY; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT CANCER;

ADENOCARCINOMA; ADULT; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RADIOIMMUNODETECTION; SENSITIVITY AND SPECIFICITY; TECHNETIUM;

EID: 0034004561     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 1 Highlights of the American Cancer Society National conference on Colorectal Cancer. Cancer Statistics 1996. Ca 46:45, 1996.
2. 2 Ramathibodi Cancer Registry Annual Report 1994. 10, 1994.
3. 3 Sugarbaker PH, Gunderson LL, Wittes RE: Colorectal cancer, In: de Vita VT Jr (Ed.). Cancer Principles & Practice of Oncology. 2nd Edition. New York, NY: Lippincott, 1982; pp. 795.
4. 4 Minton JP, Hoehn JL, Gerber DM, et al: Results of a 400 patients carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985; 55:1284-1290.
5. 5 Steele G, Zamchoch N, Wison R, et al: Results of CEA-initiated second-look surgery for recurrent colorectal cancer. Am J Surg 1980; 139:544-548.
6. 6 Attiyeh FF, Steams MW Jr: Second-look laparotomy based on CEA elevations in colorectal cancer. Cancer 1981; 47:2119-2125.
7. 7 Herrera-Ornelas L, Justiniano J, Castillo N, et al: Metastases in small lymph nodes from colon cancer. Arch Surg 1987; 122:1253-1256.
8. 8 Winzelberg GG, Grossman SJ, Rizk S, et al: Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer: Correlation with computed tomography, surgery, histopathology, immunohistology and human immune response. Cancer 1992; 69:1656-1663.
9. 9 Collier BD, Abdel-Nabi H, Doerr RJ, et al: Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: Comparison with CT. Radiology 1992; 185:179-186.
10. 111In-CYT-103 scanning in recurrent colorectal cancer-does it affect standard management? Dis Colon Rectum 1996; 39:514-519.
11. 99mTc-IMMU4 imaging in recurrent colorectal cancer: Efficacy and impact on surgical management. Nucl Med Comm 1996; 17:568-576.
12. 99mTc radioimmunoscintigraphy of colorectal cancer. Br J Cancer 1990; 10(Suppl):30-33.
13. 13 Schoentag R, Williams V and Kuhns W: The distribution of blood group substance H and CEA in colorectal carcinoma. Cancer 1984; 53:503-509.
14. 14 Goldenberg DM, Kim EE, Deland FH, et al: Radio immunodetection of cancer with radioactive antibodies to carcino-embryonic antigen. Cancer Res1980; 40:2984-2992.
15. 15 Mach JP, Carrel S, Forni M, et al: Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N Eng J Med 1980; 303:5-10.
16. 16 Goldenberg DM, Kim EE, Bennett SJ, et al: CEA radioimmuno detection in the evaluation of colorectal cancer and in the detection of occult neoplasm. Gastroenterology 1983; 84:524-532.
17. 17 Chatal JF, Saccavini JC, Furnoleau P, et al: Immunoscintigraphy of colon carcinoma. J Nucl Med 1984; 25:307-314.
18. 18 Abdel-Nabi HH, Schwartz AN, Goldfogel G, et al: Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical histopathologic, and immunohistochemical findings. Radiology 1988; 166:747-752.
19. 111In-labeled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Int J Colorectal Dis 1989; 4:97-108.
20. 99mTc-labeHed anti-CEA monoclonal antibody for tumor immunoscintigraphy: first clinical results. Nucl Med Commun 1989; 10:345-352.
21. 21 Beatty JD, Williams LE, Yamauchi K, et al: Presurgical imaging with Indium-labeled anti-carcino-embryonic antigen for colon cancer staging. Cancer Res 1990; 50(Suppl 3):922S-926S.
22. 123I-labeled Fab or F(ab'.)2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J Clin Invest 1986; 77:301-311.
23. 23 Siccardi AG, Burggi GL, Callegaio L, et al: Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenters study. Cancer Res 1989; 49:3695-3103.
24. 99mTc. J Nucl lMed 1991; 32:1052. (Abstract)
25. 25 Goldenberg DM, Wlodkowski TJ, Sharkey RM, et al: Colorectal cancer imaging with Iodine-123-labeled CEA monoclonal antibody fragments. J Nucl Med 1993; 34:61-70.
26. 111In. Nucl Med Commun 1992; 13:11-19.
27. 27 Granowska M, Britton KE, Mather SJ, et al: Radioimmunoscintigraphy with technetium-99m labeled monoclonal antibody, 1A3, in colorectal cancer. Eur J Nucl Med 1993; 20:690-698.
28. 99mTc labeled monoclonal antibodies. J Nucl Med 1987; 28:721.
29. 99mTc-labelled monoclonal antibodies; a review. Nucl Med Commun 1993; 14:347-359.
30. 30 Tormo BR, Gavilondo JV, Dominguez C, et al: CEA in colonic adenocarcinomas and precancerous lesions. An immunohistochemical study with a novel monoclonal antibody. APMIS 1989; 97:1073-1080.
31. 31 Boring CC, Squires BA, Tomy T: Cancer Statistics, 1992. CA Cancer J Clin 1992; 42:19-38.
32. 32 Galańdiuk S, Wieand HS, Moertel CG, et al: Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Sur Gynecol Obstet 1992; 174:27-32.
33. 33 Doerr RJ, Abdel-Nabi H, Krag D, et al: Radiolabeled antibody imaging in the management of colorectal cancer. Ann Surg 1991; 214:118-124.
34. 34 Abdel-Nabi-H, Doerr-RJ, Chan HW, et al: In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: safety, sensitivity, and preliminary clinical results. Radiology 1990; 175:163-71.
35. 35 Moertel CG, Fleming TR, Macdonald JS, et al: An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270:943-947.
36. 36 Doerr RJ, Abdel-Nabi H, Baker JM, et al: Detection of primary colorectal cancer with indium-111 monoclonal antibody B72.3. Arch Surg 1990; 125:1601-1605.
37. 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical management. Dis Colon Rectum 1994; 37:129-137.
38. 38 Markowitz A, Sleemi K, Freeman LM: Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma. Clin Nucl Med 1993; 18:685-700. Hepato-Gastroenterology 2000; 47:414-418